Cryotherapy
for Alzheimer’s
Cryotherapy for
Alzheimer’s Disease
According to recent scientific studies, persistent inflammation either hastens or even initiates Alzheimer’s disease process. The prevalence of Alzheimer’s disease appears to be much lower among older adults who routinely take anti-inflammatory medications, according to several epidemiological research.
Improving Symptoms with Cryotherapy for
Alzheimer’s Disease Treatment
Our clients’ treatment programmes are created specifically for them based on their unique goals, medical circumstances, and genetic predispositions.
Patients wishing to reduce their risk of acquiring Alzheimer’s due to family history, the presence of the apolipoprotein E (APOE) gene, or other risk factors such as persistent viral infection, head injury, or vascular illness, Pure Medical Cryotherapy offers a treatment programme.
For customers who have moderate dementia or Alzheimer’s disease, Pure Medical’s Cryotherapy programme offers a distinct therapeutic strategy. The frequency, intensity, and length of cryotherapy treatments vary between these two regimes.
The causes and mitigators of Alzheimer’s Disease are the foundation of our therapy strategies. We are the only facility offering a medically designed method of cryotherapy treatment for dementia and Alzheimer’s in the United Kingdom. The facts behind Alzheimer’s disease and how cryotherapy might lessen its causes and risk of occurrence serve as the foundation for our treatment strategy:
- Protein accumulation in the brain is thought to be mostly caused by chronic inflammation. The blood-brain barrier is crossed by anti-inflammatory cytokines during WBC, which reduces chronic inflammation in the brain. Pro-inflammatory cytokines are also decreased.
- The biological, brief, episodic stressor produced by whole-body cryotherapy causes the body, including the brain, to upregulate its activities. WBC can therefore slow or stop the ageing process in both the mind and body. Due to the possibility of maintaining more regular transport and elimination, this has significant consequences for the accumulation of beta-amyloid and tau proteins.
- Through the vasoconstriction/vasodilation cycle, WBC enhances the health and functionality of the vascular system. Lower vascular risk lowers the likelihood of developing Alzheimer’s.
- WBC lessens the inflammation brought on by concussions and brain injuries, which minimises the risk of persistent inflammation and subsequent protein buildup.
- WBC enhances sleeping tendencies.
What is Alzheimer’s Disease?
Alzheimer’s disease is a condition that affects the cognitive regions of the brain. It is degenerative and gradually impairs short- and long-term memory, ultimately preventing the sufferer from completing routine everyday activities. Dementia (a generic term used to describe the loss of cognitive function severe enough to interfere with executing tasks in daily life) is currently understood to have Alzheimer’s as its most common underlying cause.
Although it typically affects people over the age of 65, this gradual degenerative disease is not a normal aspect of ageing. It is thought that the disease has already left its imprint on the microscopic level of the brain long before any symptoms manifest. Patients with Alzheimer’s disease often pass away four to eight years following their diagnosis. This condition is degenerative and progressive because it gradually impairs brain function and, eventually, human life.
Short-term memory loss will start to affect Alzheimer’s patients, typically starting with little, insignificant gaps. Both short-term memory and long-term memory get elusive with age. A conversation becomes impossible as the disease progresses and takes control of the patient’s brain since they are unable to respond to their surroundings.
Alzheimer’s disease currently has no known allopathic medicinal treatment. Patients and their families get management skills for the degenerative illness that causes brain neuron death and ultimately results in death. Exciting advancements in biomedical research show the potential benefits of whole body cryotherapy as a preventive measure and, ultimately, as a means of symptom eradication.
Hope For Families And Individuals Living With Alzheimer’s disease
Whole-body cryotherapy helps prevent Alzheimer’s and other forms of dementia, while additional research is required to assess its efficacy. Because cryotherapy has anti-oxidant and anti-inflammatory properties, it is thought that this may be a successful treatment for the oxidative and inflammatory stress reactions associated with Alzheimer’s.
How frequently should I use a Cryotherapy Chamber for Alzheimer’s Disease treatment?
Our treatment programmes are tailored to the patient, It’s crucial to pay attention to your body and stop using the cryotherapy chamber if you feel any negative side effects.
If you or someone you love is suffering from Alzheimer’s disease please contact Pure Medical for a Cryotherapy treatment consultation.
